SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-218037
Filing Date
2023-08-22
Accepted
2023-08-22 16:31:58
Documents
14
Period of Report
2023-08-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d510574d8k.htm   iXBRL 8-K 29373
2 EX-10.1 d510574dex101.htm EX-10.1 148207
3 EX-10.2 d510574dex102.htm EX-10.2 75288
  Complete submission text file 0001193125-23-218037.txt   429950

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA vcnx-20230818.xsd EX-101.SCH 2842
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vcnx-20230818_lab.xml EX-101.LAB 17979
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vcnx-20230818_pre.xml EX-101.PRE 11253
8 EXTRACTED XBRL INSTANCE DOCUMENT d510574d8k_htm.xml XML 3390
Mailing Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620
Business Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620 585-271-2700
VACCINEX, INC. (Filer) CIK: 0001205922 (see all company filings)

IRS No.: 161603202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38624 | Film No.: 231193937
SIC: 2834 Pharmaceutical Preparations